Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nagoya Journal of Medical Science|April 21, 2012
Extravasation of pegylated-liposomal doxorubicin: favorable outcome after immediate subcutaneous administration of corticosteroidsAyako Mitsuma, Masataka Sawaki, Takashi Shibata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2025
[Challenges and Prospects for Medical Oncology under the Emerging Infectious Disease Disaster]Sachi Morita, Noritoshi Kobayashi, Junji Tsurutani, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 4, 2013
Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancerTomoyo Oguri, Ayako Mitsuma, Megumi Inada-Inoue, et al.
Breast Cancer (Tokyo, Japan)|July 11, 2014
Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancerMihoko Sugishita, Tsuneo Imai, Toyone Kikumori, et al.
Oncology Letters|December 2, 2015
Pazopanib monotherapy in a patient with a malignant granular cell tumor originating from the right orbit: A case reportSachi Morita, Mariko Hiramatsu, Mihoko Sugishita, et al.
Molecular and Clinical Oncology|June 7, 2021
Next-generation genome sequencing of a matched normal-tumor pair from a patient with intractable gestational choriocarcinoma: A case reportKaoru Niimi, Eiko Yamamoto, Sachi Morita, et al.
Investigational New Drugs|October 4, 2011
Phase I dose-escalating study of panobinostat (LBH589) administered intravenously to Japanese patients with advanced solid tumorsSachi Morita, Satoshi Oizumi, Hironobu Minami, et al.
International Journal of Clinical Oncology|August 10, 2017
Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in JapanSachi Morita, Toyone Kikumori, Nobuyuki Tsunoda, et al.
International Journal of Clinical Oncology|January 1, 2021
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in JapanKuniko Sunami, Yoichi Naito, Eriko Aimono, et al.
Nagoya Journal of Medical Science|December 14, 2020
Chemotherapy for biliary tract cancer: real-world experience in a single instituteOsamu Maeda, Tomoki Ebata, Tomoya Shimokata, et al.
Pageof 3